Page last updated: 2024-10-24

verapamil and Hyperaldosteronism

verapamil has been researched along with Hyperaldosteronism in 4 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.

Research Excerpts

ExcerptRelevanceReference
" In order to evaluate the effect of a calcium channel blocking agent (Verapamil) in conditions of abnormal aldosterone secretion, we have studied 11 patients with primary aldosteronism, 5 with idiopathic hyperaldosteronism (IHA) and 6 with aldosterone producing adenoma (APA)."7.67Effect of verapamil on aldosterone secretion in primary aldosteronism. ( Mantero, F; Murgia, A; Opocher, G; Rocco, S, 1987)
"Glycyrrhizin can cause pseudohyperaldosteronism and thereby result in hypertension and hypokalaemia."5.48Potassium chloride mixture may maintain hypokalaemia and hypertension. ( Borg, R; Hansen, D; Mandoe, MJ, 2018)
"Hydralazine, doxazosin, and verapamil are currently recommended by the Endocrine Society as acceptable bridging treatment in those in whom full cessation of antihypertensive medication is infeasible during screening for primary aldosteronism (PA)."4.31The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio Thereof. ( Alnazer, RM; de Leeuw, PW; Kroon, AA; Veldhuizen, GP, 2023)
" In order to evaluate the effect of a calcium channel blocking agent (Verapamil) in conditions of abnormal aldosterone secretion, we have studied 11 patients with primary aldosteronism, 5 with idiopathic hyperaldosteronism (IHA) and 6 with aldosterone producing adenoma (APA)."3.67Effect of verapamil on aldosterone secretion in primary aldosteronism. ( Mantero, F; Murgia, A; Opocher, G; Rocco, S, 1987)
"Glycyrrhizin can cause pseudohyperaldosteronism and thereby result in hypertension and hypokalaemia."1.48Potassium chloride mixture may maintain hypokalaemia and hypertension. ( Borg, R; Hansen, D; Mandoe, MJ, 2018)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Veldhuizen, GP1
Alnazer, RM1
de Leeuw, PW1
Kroon, AA1
Mandoe, MJ1
Borg, R1
Hansen, D1
Kaesemeyer, WH1
Prisant, LM1
Carr, AA1
Opocher, G1
Rocco, S1
Murgia, A1
Mantero, F1

Other Studies

4 other studies available for verapamil and Hyperaldosteronism

ArticleYear
The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio Thereof.
    Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:2

    Topics: Aldosterone; Antihypertensive Agents; Doxazosin; Humans; Hydralazine; Hyperaldosteronism; Hypertensi

2023
Potassium chloride mixture may maintain hypokalaemia and hypertension.
    BMJ case reports, 2018, Dec-14, Volume: 11, Issue:1

    Topics: Diagnosis, Differential; Female; Glycyrrhiza; Glycyrrhizic Acid; Humans; Hyperaldosteronism; Hyperte

2018
Verapamil and nifedipine in combination for the treatment of hypertrophy heart disease.
    American journal of hypertension, 1991, Volume: 4, Issue:10 Pt 1

    Topics: Adrenal Gland Diseases; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Humans;

1991
Effect of verapamil on aldosterone secretion in primary aldosteronism.
    Journal of endocrinological investigation, 1987, Volume: 10, Issue:5

    Topics: Aldosterone; Humans; Hyperaldosteronism; Verapamil

1987